Noradrenaline (Norepinephrine) Equity 1 mg/mL Concentrate for solution for infusion
PDF Leaflet Revision Date: 23 February 2026
Clinical Summary
Quick overview from the medicine insert
Indication
Emergency restoration of blood pressure in acute hypotension.
Dosage (summary)
Initial infusion rate: 10-20 mL/hour (0.4-0.8 mg/hour) for 70 kg adults; titrate as needed.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
May impair placental perfusion; safety in breastfeeding not established.
Key Drug Interactions
- Volatile halogen anaesthetics
- Tricyclic antidepressants
- Digitalis glycosides
Contraindications
- Hypersensitivity to noradrenaline
- Hypotension due to hypovolaemia
Common side effects
- Tachycardia
- Hypertension
- Anxiety
- Nausea
Counselling Points
- Dilute before use
- Monitor blood pressure continuously
- Report any adverse effects
Serious warnings
- Risk of extravasation
- Monitor for ischemia
- Use only under medical supervision
Important Disclaimer
The Noradrenaline (Norepinephrine) Equity 1 mg/mL Concentrate for solution for infusion professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
